William Creasman to Carcinoma, Squamous Cell
This is a "connection" page, showing publications William Creasman has written about Carcinoma, Squamous Cell.
Connection Strength
1.364
-
How valid are current cervical cancer prognostic factors that are used to recommend adjunctive radiation therapy after radical surgery? Am J Obstet Gynecol. 2009 Sep; 201(3):260.e1-3.
Score: 0.230
-
Circulating levels of insulin-like growth factor-II and IGF-binding protein 3 in cervical cancer. Gynecol Oncol. 2003 Dec; 91(3):486-93.
Score: 0.156
-
Expression of cyclooxygenase-2 in cervical, endometrial, and ovarian malignancies. Am J Obstet Gynecol. 2003 May; 188(5):1174-6.
Score: 0.150
-
Early invasive carcinoma of the cervix (3 to 5 mm invasion): risk factors and prognosis. A Gynecologic Oncology Group study. Am J Obstet Gynecol. 1998 Jan; 178(1 Pt 1):62-5.
Score: 0.104
-
Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study. Gynecol Oncol. 1995 Jun; 57(3):412-6.
Score: 0.087
-
Adverse effect of electrosurgical loop excision on assignment of FIGO stage in cervical cancer: report of two cases. Gynecol Oncol. 1994 Nov; 55(2):313-7.
Score: 0.083
-
Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group. Obstet Gynecol. 1992 Apr; 79(4):490-7.
Score: 0.070
-
A case of parametrial lymph node involvement in stage IA2 squamous cell carcinoma of the cervix treated with radical hysterectomy and a review of the literature: a case report. J Low Genit Tract Dis. 2012 Apr; 16(2):145-8.
Score: 0.070
-
A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group study. J Clin Oncol. 1989 Oct; 7(10):1462-8.
Score: 0.059
-
A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in carcinoma of the cervix. A preliminary report of a Gynecologic Oncology Group study. Am J Obstet Gynecol. 1988 Jul; 159(1):87-94.
Score: 0.054
-
Radical hysterectomy as therapy for early carcinoma of the cervix. Am J Obstet Gynecol. 1986 Nov; 155(5):964-9.
Score: 0.048
-
Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinoma. Am J Obstet Gynecol. 1985 Apr 01; 151(7):922-32.
Score: 0.043
-
The National Cancer Data Base report on cancer of the vagina. Cancer. 1998 Sep 01; 83(5):1033-40.
Score: 0.027
-
Operative management of early invasive epidermoid carcinoma of the vulva. Am J Obstet Gynecol. 1975 Oct 15; 123(4):349-55.
Score: 0.022
-
Meningeal carcinomatosis secondary to advanced squamous cell carcinoma of the cervix: a case report. Meningeal metastasis of advenced cervical cancer. Gynecol Oncol. 1975 Sep; 3(3):201-4.
Score: 0.022
-
Microinvasive carcinoma of the cervix. Clin Obstet Gynecol. 1973 Jun; 16(2):261-75.
Score: 0.019
-
Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol. 1991 Jan; 40(1):55-65.
Score: 0.016
-
Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol. 1990 Sep; 38(3):352-7.
Score: 0.016
-
A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group Study. Gynecol Oncol. 1989 Dec; 35(3):314-20.
Score: 0.015
-
Combined adverse effect of African American race and deep stromal invasion on survival following radical hysterectomy for cervical cancer. Am J Obstet Gynecol. 2008 Aug; 199(2):196.e1-7.
Score: 0.013
-
Phase II trial of cisplatin in advanced or recurrent cancer of the vagina: a Gynecologic Oncology Group Study. Gynecol Oncol. 1986 Jan; 23(1):101-4.
Score: 0.011
-
Postoperative pelvic vein thrombosis and pulmonary embolism detected by indium 111-labeled platelet imaging: a case report. Am J Obstet Gynecol. 1984 Aug 01; 149(7):796-8.
Score: 0.010
-
Phase II trial of VP-16-213 in the treatment of advanced squamous cell carcinoma of the cervix and adenocarcinoma of the ovary: a Gynecologic Oncology Group Study. Cancer Treat Rep. 1979 Nov-Dec; 63(11-12):2089-92.
Score: 0.007
-
Unusual metastasis in carcinoma of the cervix uteri. Surg Gynecol Obstet. 1979 May; 148(5):728-30.
Score: 0.007
-
An alternate approach to early cancer of the vulva. Am J Obstet Gynecol. 1979 Apr 01; 133(7):825-32.
Score: 0.007
-
Toxicity manifestations following intravenous Corynebacterium parvum administration to patients with ovarian and cervical carcinoma. Am J Obstet Gynecol. 1978 Nov 01; 132(5):555-60.
Score: 0.007
-
Ovarian metastases in stage IB carcinoma of the cervix: a Gynecologic Oncology Group study. Am J Obstet Gynecol. 1992 Jan; 166(1 Pt 1):50-3.
Score: 0.004
-
Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes (a Gynecologic Oncology Group study). Gynecol Oncol. 1984 Sep; 19(1):8-16.
Score: 0.003
-
Risk of exogenous estrogen therapy and endometrial cancer. Am J Obstet Gynecol. 1980 May 01; 137(1):85-91.
Score: 0.002
-
Results and complications of operative staging in cervical cancer: experience of the Gynecologic Oncology Group. Gynecol Oncol. 1980 Feb; 9(1):90-8.
Score: 0.002